Rasmussen's encephalitis: An autoimmune disorder?

Current Opinion in Neurology

Volumn 9, Issue 2, 1996, Pages 141-145

  Andrews, P Ian ^a   McNamara, James O ^a,b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Box 3676 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; GLUTAMATE RECEPTOR;

AUTOIMMUNITY; CELLULAR IMMUNITY; CHILD; ENCEPHALITIS; EPILEPSY; ETIOLOGY; HUMAN; NONHUMAN; PATHOGENESIS; RABBIT; SHORT SURVEY;

EID: 0029947140     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-199604000-00015     Document Type: Short Survey

References (45)

1. Kopeloff LM, Barrera SE, Kopeloff N: Recurrent convulsive seizures in animals produced by immunologic and chemical means. Am J Psychiatry 1942, 98:881-902.
2. Rasmussen T, Olszweski J, Lloyd-Smith DK: Focal seizures due to chronic localized encephalitis. Neurology 1958, 8:435-455.
3. Anderman F: Chronic encephalitis and epilepsy: Rasmussen's encephalitis. Stoneham, MA: Butterworth-Heinemann; 1991.
4. McLachlan RS, Girvin JP, Blume WT, Reichman H: Rasmussen's chronic encephalitis in adults. Arch Neurol 1993, 50:269-274.
5. Andrews PI, Rogers SW, Cram BJ, Gahring LC, Lewis DV, DeLong GR, McNamara JO: Rasmussen's encephalitis (RE) is an autoimmune disease directed against glutamate receptors (GluRs): clinical, serologic and pathologic evidence. Neurology 1994, 44(suppl 2):A273.
6. Pardo CA, Arroyo S, Vining EPG, Freeman JM: Neuronal injury in Rasmussen's chronic encephalitis is mediated by cytotoxic T-cells. Epilepsia 1994, 35(suppl 8):89.
7. Farrell MA, Droogan O, Secor DL, Poukens V, Quinn B, Vintyers HV: Chronic encephalitis associated with epilepsy: immunohistochemical and ultrastructural studies: Acta Neuropathologica 1995, 89:313-321. This detailed characterization of the inflammatory pathology in RE facilitates comparisons with viral encephalitis and other inflammatory central nervous system disorders.
8. Rasmussen T, Andermann F: Update on the syndrome of 'chronic encephalitis' and epilepsy. Cleve Clin J Med 1989, 56(suppl 1):81-84.
9. Honavar M, Janota I, Polkey CE: Rasmussen's encephalitis in surgery for epilepsy. Dev Med Child Neurol 1992, 34:3-14.
10. Dalos N, Vining EPG, Carson B, Freeman JM: Rasmussen's encephalitis: clinical recognition and surgical management Epilepsia 1986, 27:594.
11. Hollman M, Heinemann S: Cloned glutamate receptors. Annu Rev Neurosci 1994, 17:31108.
12. Rogers SW, Andrews PI, Gahring LC, Whisenand T Cauley K, Cram B, Hughes TE, Heinemann SF, McNamara JO: Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science 1994, 265:648-651. RE-like clinical and pathologic features were found in rabbits immunized with GluR3 protein. GluR3 autoantibodies were identified in sera of RE patients. An improvement in neurologic function and seizure frequency was seen in one patient with RE treated with PEX.
13. Bolter J, Hollmann M, O'Shea-Greenfield A, Hartley M, Deneris E, Maron C, Heinemann SF: Molecular cloning and functional expression of glutamate receptor subunit genes. Science 1990, 249:1033-1037.
14. Keinanen K, Wisden W, Sommer B, Werner P, Herb A, Verdoom TA, Sakmann G, Seeburg PH: A family of AMPA-selective glutamate receptors. Science 1990, 249:556-560.
15. Andrews PI, Dichter MA, Berkovic SF, Newton MR, McNamara JO: Plasmapheresis in Rasmussen's encephalitis. Neurology 1996, 46:242-246. Marked improvement on neurologic dysfunction and seizure frequency in three of four patients with RE treated by recurrent PEX.
16. Twyman RE, Gahring LC, Spiess J, Rogers SW: Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site. Neuron 1995, 14:755-762. Sera from rabbits immunized with a portion of the extracellular region of GluR3 protein and sera from patients with RE have glutamate agonist properties on the subset of cell with AMPA/KA receptors in cultured fetal mouse cortical cells. The region of GluR3 with which rabbit GluR3 antisera and RE patients' sera interact coincides with an important site determining agonist specificity.
17. Stem-Bach Y, Bettler B, Hartley M, Sheppard PO, O'Hara PJ, Heinemann SF: Agonist selectivity of glutamate receptors is specified by two domains structurally related to bacterial amino acid-binding proteins. Neuron 1994, 13:1345-1357.
18. O'Hara P, Sheppard PO, Thogersen H, Venezia D, Haldeman BA, McGrane V, Houamed KH, Thomsen C, Gilbert TL, Mulvihill ER: The ligand-binding domain in metabotropic glutamate receptors is related to bacterial periplasmic binding domains. Neuron 1993, 11:41-52.
19. Oldstone MBA: Molecular mimicry and autoimmune disease. Cell 1987, 50:819-820.
20. Nitsch C, Hubanaue H: Distant blood-brain barrier openings in subfields of the rat hippocampus after intrastriatal injections of kainic acid but not ibotenic acid. Neurosci Lett 1986, 64:53-58.
21. Mihaly A, Joo F, Szente M: Vasogenic brain edema in focal 4-aminopyridine seizures: the role of neuronal hyperactivity. J Hirnforsch 1990, 31:77-86.
22. Bangash IH, Kandt RS, D'Souza BJ, Heinz R: Hyperdensity on CT after seizure: a pitfall. J Child Neurol 1987, 2:276-278.
23. Dulac O, Robvain O, Chiron C: High-dose steroid treatment of epilepsia partialis continua due to chronic focal encephalitis. In Chronic encephalitis and epilepsy: Rasmussen's syndrome. Edited by Anderman F. Stoneham: Butterworth-Heinemann; 1991: 193-199.
24. Walsh PJ: Treatment of Rasmussen's syndrome with intravenous gammaglobulin. In Chronic encephalitis and epilepsy: Rasmussen's syndrome. Edited by Stoneham AF: Butterworth-Heinemann, 1991:201-204.
25. Hart YM, Cortez M, Andermann F, Hwang P, Fish DR, Dulac O, Silver K, Fejerman N, Cross H, Sherwin A, Caraballo R: Medical treatment of Rasmussen's syndrome (chronic encephalitis and epilepsy). Neurology 1994, 44:1030-1036.
26. Chinchilla D, Dulac O, Robain O, Plouin P, Ponsot G, Pinel JF, Graber D: Reappraisal of Rasmussen's syndrome with special emphasis on treatment with high doses of steroids. J Neurol Neurosurg Psychiatry 1994, 57:1325-1333. Marked improvement in patients with biopsy-confirmed or clinically diagnosed RE after treatment with high-dose steroids early (<15 months) in the disease course.
27. Hart YM, Andermann E, Rasmussen T, Robitaille Y, Laxer K: Double pathology in Rasmussen's syndrome of chronic encephalitis and epilepsy. Epilepsia 1993, 34(suppl 2):14.
28. Robataille Y: Neuropathologic aspects of chronic encephalitis. In Chronic encephalitis and epilepsy: Rasmussen's syndrome. Edited by Stoneham AF: Butterworth-Heinemann; 1991:79-110.
29. Peyser J, Trevino J, Resnick T: Epilepsia partialis continua. Int Pediatrics 1992, 7:272-275.
30. Harvey SA, Andermann F, Hopkins IJ, Kirkham TH, Berkovic SF: Chronic encephalitis (Rasmussen's syndrome) and ipsilateral uveitis. Ann Neurol 1992, 32:826-829.
31. Fukuda T, Oguni H, Yanagaki S, Fukuyama Y, Kogure M, Shimizu H, Oda M: Chronic localized encephalitis (Rasmussen's syndrome) preceded by ipsilateral uveitis: a case report. Epilepsia 1994, 35:1328-1331.
32. Hughes TE, Hermans-Borgmeyer I, Heinemann S: Differential expression of glutamate receptor genes (GluR1-5) in the rat retina. Visual Neuroscience 1992, 8:49-55.
33. Spies JM, Westland KW, Bonner JG, Pollard JD: Intraneural activated T cells cause focal breakdown of the blood-nerve barrier. Brain 1995, 118:858-868. Activated T cells injected into peripheral nerves cause focal breakdown of the blood-nerve barrier, allowing circulating antimyelin antibodies to enter the endoneurium and produce focal demyelinalion.
34. Pardo CA, Vining EPG, Arroyo S, Freeman JM: Cytokines are involved in the immunopathological mechanisms of neuronal injury in Rasmussen's syndrome. Epilepsia 1995, 36(suppl 4):30.
35. Yi L, Uccelli A, Laxer KD, Oksenberg JR: Restricted T-cell repertoire in Rasmussen encephalitis brain lesions. Neurology 1995, 45(suppl 4):A295.
36. Asher DM, Gajdusek DC: Virologic studies in chronic encephalitis. In Chronic encephalitis and epilepsy: Rasmussen's syndrome. Edited by Stoneham AF: Butterworth-Heinemann; 1991:147-158.
37. Atkins MR, Terrell W, Hulette CM: Rasmussen's syndrome: a study of potential viral etiology. Clin Neuropathol 1995, 4:7-12.
38. Power C, Poland SD, Blume WT, Girvin JP, Rice GPA: Cytomegalovirus and Rasmussen's encephalitis. Lancet 1990, 336:1282-1284.
39. Farrell MA, DeRosa MJ, Curran JG, Secor DL, Cornford M, Comair YG, Peacock WJ, Shields WD, Vinters HV: Neuropathologic findings in cortical resections (including hemispherectomies) performed for the treatment of intractable childhood epilepsy. Acta Neuropathol 1992, 83:246-259.
40. Walter G, Renella RR: Epstein-Barr virus in the brain and Rasmussen's encephalitis [Letter]. Lancet 1989, 335:279-280.
41. Friedman H, Ch'ien L, Parham D: Virus in the brain of child with hemiplegia, hemiconvulsions and epilepsy [Letter]. Lancet 1977, 2:666.
42. Jay V, Becker LE, Otsubo H: Chronic encephalitis and epilepsy (Rasmussen's encephalitis): detection of Cytomegalovirus and herpes simplex virus 1 by the polymerase chain reaction and in situ hybridization. Neurology 1995, 45:108-117.
43. Sterm H, Elek SD: The incidence of infection with Cytomegalovirus in a normal population. J Hygiene 1965, 63:79-87.
44. Bruggman CA: Cytomegalovirus and latency: an overview. Virchows Arch B Cell Pathol 1993, 64:325-333.
45. Laxer KD: Temporal lobe epilepsy with inflammatory pathologic changes. Chronic encephalitis and epilepsy: Rasmussen's encephalitis. Edited by Anderman F. Stoneham, MA: Butterworth-Heinemann; 1991.